ETHOSUXIMIDE 250 MG CAPSULE

ETHOSUXIMIDE
$0.2533per EA

Strength

250 mg/1

Manufacturer

Chartwell RX LLC

NDC

62135079012

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

ETHOSUXIMIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA200892

On Market Since

9/9/2015

Pharmacological Classes

Anti-epileptic Agent
Decreased Central Nervous System Disorganized Electrical Activity

Price History

1W

0.0%

1M

+2.5%

3M

+2.3%

6M

+3.1%

1Y

-0.6%

3Y

N/A

5Y

N/A

All

-27.8%